Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank29
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-51.51
↓ 39% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive declineCompressed
Average
-37.17
Historical baseline
PeriodValueYoY Change
2025-51.51-185.9%
2024-18.02-311.5%
2023-4.38+24.7%
2022-5.81+82.6%
2021-33.45-6.8%
2020-31.33+63.6%
2019-85.97-28.6%
2018-66.86-